Celator Pharmaceuticals, Inc.
Celator Pharmaceuticals Selected to Participate in NCI's Nanotechnology Characterization Laboratory Assay Cascade for Characterization of Nanoparticle Prodrug Delivery Platform
Published in Medical Letter on the CDC and FDA, March 7th, 2010
The agreement is part of the NCI's Advanced Technology Partnerships Initiative, which aims to accelerate the delivery of new products to cancer patients through the strategic application of advanced technologies and effective translational research partnerships.
The current material transfer agreement focuses on Celator's hydrophobic docetaxel...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Canadian Medical Association Journal
H1N1 learnings: Risk factors for severe outcomes among patients admitted to hospital with H1N1 - Massachusetts General Hospital
Shifting cellular energy metabolism may help treat cardiovascular disease - Breast Cancer
Research on breast cancer described by A.T. Perez and colleagues - Colon Cancer
Researchers at University Hospital target colon cancer - Embera NeuroTherapeutics, Inc.
Embera NeuroTherapeutics Forms Clinical Development Collaboration with Exponential Pharma Ventures - Immunization
Research from M.B. Stoddard and co-authors in the area of immunization published - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
